
Vaxart urges shareholders to vote for all six director nominees to secure biotech growth and funding.
Vaxart, a clinical-stage biotech company, has published a presentation urging shareholders to vote for all six of its director nominees at the upcoming Annual Meeting. The company highlights its progress in developing oral vaccines for COVID-19, noro...

